Dokkyo Medical University’s publication on International Journal of Molecular Sciences.
SMC announced that Dokkyo Medical University has published the results of a study using STAM™ model on International Journal of Molecular Sciences.
Title: “The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma”